A Study to Assess Selected Biomarkers in Subjects Requiring Daily Inhaled Corticosteroids for Persistent Asthma

Exclusion Criteria

• •Any medical condition that, in the opinion of the investigator or medical monitor, would interfere with interpretation of subject safety or study results
• •Concurrent enrollment in another clinical study
• •Use of immunosuppressive medication within 3 months prior to screening
• •Acute upper or lower respiratory infections requiring antibiotics or antiviral medications with in 30 days prior to screening or during screning period.
• •Receipt of immunoglobulin or blood products within 30 days prior to screening or during the screening period
• •Receipt of any investigational non-biological drug therapy within 30 days or 5 half-lives prior to screening whichever is longer; or receipt of any marketed or investigational biologic within 6 months or 5 half-lives prior to screening whichever is longer
• •Pregnant, lactating, or breastfeeding woman
• •Diagnosis of lung disease other than persistent asthma
• •History of smoking ≥10 pack years or any smoking within 12 months prior to screening
• •History of active, infectious hepatitis A, B, C or human immunodeficiency virus (HIV)